Explore jobs
Find specific jobs
Explore careers
Explore professions
Best companies
Explore companies
Zippia finds jobs where you're a top candidate and applies on your behalf.
Progyny's peak revenue was $1.2B in 2024. The peak quarterly revenue was $304.1M in 2024(q2).
Progyny's revenue increased from $105.4m in 2018 to $1.2B currently. That's a 1,007.42% change in annual revenue.
| Fiscal year / year | Progyny revenue |
|---|---|
| 2018 | $105.4M |
| 2019 | $229.7M |
| 2020 | $344.9M |
| 2021 | $500.6M |
| 2022 | $786.9M |
| 2023 | $1.1B |
| 2024 | $1.2B |
Rate Progyny's financial transparency
Progyny saw the greatest revenue growth in 2019, when revenue increased by 117.92%.
Progyny had the lowest revenue growth in 2021, when revenue changed by 45.17%.
| Year | Progyny growth |
|---|---|
| 2019 | 118%↑ |
| 2020 | 50%↑ |
| 2021 | 45%↑ |
| 2022 | 57%↑ |
| 2023 | 38%↑ |
| 2024 | 7%↑ |
| Year | Q1 | Q2 | Q3 | Q4 |
|---|---|---|---|---|
| 2019 | - | - | $61.2M | $65.1M |
| 2020 | $81.0M | $64.6M | $98.9M | $100.3M |
| 2021 | $122.1M | $128.7M | $122.3M | $127.6M |
| 2022 | $172.2M | $195.0M | $205.4M | $214.3M |
| 2023 | $258.4M | $279.4M | $280.9M | $269.9M |
| 2024 | $278.1M | $304.1M | $286.6M | $298.4M |
Do you work at Progyny?
Is Progyny transparent about its revenue structure?
| CEO | Peter Anevski |
| Industry | Health Care Equipment & Services |
| Company Type | Public |
| Employees Number | 210 |
| Date Founded | 2008 |
| Headquarters | New York, New York |
| Number of Locations | 27 |
| Revenue | $1.2B |
| Net Income | $30,358,000 |
| Gross Proft | $253.4M (2024) |
| Tax Rate | 0.3% |
| Total Assets | $542,986,000 |
| Ticker | PGNY |
Progyny received early financing of $20.0M on 2012-02-01.
| Series | Round size | Date |
|---|---|---|
| Series A | $20M | 02/2012 |
| Series B | $18M | 05/2012 |
| Series B | $5.5M | 09/2013 |
| Series B | $34.3M | 03/2015 |
| Series B | $3.8M | 05/2015 |
| Series B | $3M | 07/2015 |
| Series B | $14.7M | 07/2016 |
| Series Unknown | $1.2M | 08/2016 |
| Series B | $10M | 05/2017 |
| Series Unknown | $5M | 11/2017 |
| Investors | Security type |
|---|---|
| SR One | Series B |
| M Ventures | Series B |
| Union Grove Venture Partners | Series B |
| Mellon Ventures | Series B |
| Kleiner Perkins | Series B |
| TPG Biotech | Series B |
| SR One | Series B |
| Kleiner Perkins | Series B |
| TPG Biotech | Series B |
Progyny's top competitor, GE Healthcare Holdings Inc., earned an annual revenue of $18.3B.
Progyny's smallest competitor is Synlogic with revenue of $8.0K last year.
| Company name | Average salary | Revenue | Employee size | Job openings |
|---|---|---|---|---|
| Synlogic | $46,487 | $8,000 | 74 | - |
| Bionano Genomics | $46,489 | $30.8M | 50 | 6 |
| Rigel Pharmaceuticals | $83,403 | $179.3M | 158 | 6 |
| Global Blood Therapeutics | $92,651 | $194.7M | 457 | - |
| Epizyme | $86,952 | $37.4M | 124 | - |
| Constellation Pharmaceuticals | $65,259 | $4.7M | 82 | - |
| e+mc2 | $51,532 | $430,000 | 9 | - |
| GE Healthcare Holdings Inc. | $85,963 | $18.3B | 54,000 | 921 |
| Vital Images | $84,860 | $60.0M | 200 | 1 |
| NantHealth | $87,637 | $67.0M | 543 | - |
Zippia gives an in-depth look into the details of Progyny, including salaries, political affiliations, employee data, and more, in order to inform job seekers about Progyny. The employee data is based on information from people who have self-reported their past or current employments at Progyny. The data on this page is also based on data sources collected from public and open data sources on the Internet and other locations, as well as proprietary data we licensed from other companies. Sources of data may include, but are not limited to, the BLS, company filings, estimates based on those filings, H1B filings, and other public and private datasets. While we have made attempts to ensure that the information displayed are correct, Zippia is not responsible for any errors or omissions or for the results obtained from the use of this information. None of the information on this page has been provided or approved by Progyny. The data presented on this page does not represent the view of Progyny and its employees or that of Zippia.
Progyny may also be known as or be related to PROGYNY, INC., Progyny, Progyny Inc and Progyny, Inc.